Novo Nordisk (NVO) and Eli Lilly (LLY) are planning to announce new drug pricing deals with the White House, including for their blockbuster weight loss drugs, Max Bayer of Endpoints News reports.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- Eli Lilly asks European nations to scrap clawback taxes, FT says
- Eli Lilly (LLY) to Build $3 Billion European Plant to Manufacture Weight-Loss Pill
- Eli Lilly’s New Study on Brenipatide: A Potential Game-Changer in Smoking Cessation
- Eli Lilly to build new $3B facility in Katwijk, the Netherlands
- Eli Lilly’s Earnings Call: Robust Growth and Strategic Wins